Physician profile
Jenna M Benoit
NPI 1790110666
$6,701.29
in general payments reported to CMS, 2019-2025
45 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,359 · 2022: $1,050 · 2023: $1,151 · 2024: $1,133 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,261 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,260.84 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,019.86 | 2021-2025 | |
| Novo Nordisk INC | $701.04 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Tris Pharma INC | $354.39 | 2023-2025 | Dyanavel Xr |
| Viiv Healthcare Company | $344.12 | 2022-2025 | Apretude |
| Gilead Sciences, INC. | $330.51 | 2021-2025 | |
| Lilly USA, LLC | $329.05 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceuticals, INC. | $323.27 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $291.00 | 2021-2023 | Trintellix |
| Neos Therapeutics, LP | $210.01 | 2021-2025 | Adzenys Xr-Odt |
| Pfizer INC. | $184.31 | 2022-2025 | |
| Amgen INC. | $161.47 | 2022-2025 | Repatha, Otezla |
| Exact Sciences Corporation | $127.45 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corium, LLC | $121.82 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $93.51 | 2021-2025 | Pediarix, Bexsero, Rotarix |
| Supernus Pharmaceuticals, INC. | $82.07 | 2022-2023 | Qelbree |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Benoit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.